CHNA Holdings

CNCR

The China BioPharma ETF

ETF Information as of 12/18/2018

ETF Holdings

COMPANY NAME ↓ TICKER ↓ CUSIP ↓ SHARES ↓ MARKET VALUE ↓ % OF NET ASSETS ↓
SINOPHARM GROUP CO 1099 HK B3ZVDV0 28,000 $116,185.54 5.90%
AUSTAR LIFESCIENCE 6118 HK BSHYHZ4 136,000 $107,996.55 5.48%
BEIGENE LTD BGNE 07725L102 708 $94,121.52 4.78%
WUXI BIOLOGICS (CA 2269 HK BZ3C3R5 13,000 $92,842.30 4.71%
HUTCHISON CHINA MEDITECH LTD SPONSORED ADR HCM 44842L103 2,757 $87,920.73 4.46%
ZAI LAB LTD ZLAB 98887Q104 3,856 $87,646.88 4.45%
SIHUAN PHARM HLDG 460 HK B4X3RF7 426,000 $84,434.64 4.29%
SSY GROUP LIMITED 2005 HK BYP9J68 104,000 $83,649.50 4.25%
GUANGZHOU BAIYUNSH 874 HK 6084387 22,000 $83,130.33 4.22%
SHANGHAI FOSUN PHA 2196 HK B8XBQ96 27,000 $81,998.66 4.16%
CHINA RES PHARM GR 3320 HK BYNGG26 60,000 $80,866.98 4.11%
SHANGHAI PHARMACEU 2607 HK B4Q4CJ6 33,600 $73,298.94 3.72%
CSPC PHARMACEUTICA 1093 HK 6191997 48,000 $71,813.56 3.65%
CHINA BIOLOGIC PRODS HLDGS INC COM CBPO G21515104 916 $66,501.60 3.38%
CHINA GRAND PHARMA 512 HK B00W4D6 140,000 $65,343.18 3.32%
SINO BIOPHARMACEUT 1177 HK B00XSF9 92,000 $62,703.88 3.18%
LUYE PHARMA GP LTD 2186 HK BNQ4GF3 93,000 $62,552.99 3.18%
YICHANG HEC CHANGJ 1558 HK BYPHSW1 17,600 $60,540.26 3.07%
LIVZON PHARMACEUTI 1513 HK BJ34614 19,400 $58,669.48 2.98%
GENSCRIPT BIOTECH 1548 HK BD9Q2J2 40,000 $57,082.57 2.90%
SHANGHAI HAOHAI BI 6826 HK BWZN1R1 12,200 $54,601.83 2.77%
3SBIO INC 1530 HK BY9D3L9 41,000 $53,791.12 2.73%
CELLULAR BIOMEDICINE GROUP INC COM NEW CBMG 15117P102 2,904 $53,201.28 2.70%
LEES PHARMACEUTICA 950 HK BQZF1T7 66,000 $48,696.65 2.47%
ASCLETIS PHARMA IN 1672 HK BFLTDL2 62,000 $48,123.78 2.44%
ESSEX BIO-TECHNOLO 1061 HK 6370291 74,000 $47,880.82 2.43%
CHINA MEDICAL SYS 867 HK B6WY993 49,000 $47,056.04 2.39%
CASI PHARMACEUTICALS INC CASI 14757U109 8,508 $36,669.48 1.86%
Cash & Other Cash&Other Cash&Other -201.10 $-201.10 -0.01%
*ETF holdings and allocations are subject to change at any time and should not be interpreted as an offer of these securities